Sinopharm Group (01099.HK): Sinopharm Accord achieved a net profit attributable to the parent company of RMB 346 million in the third quarter, a year-on-year increase of 18.91%.

Zhitong Finance APP News, Sinopharm Group (01099.HK) announced that Sinopharm Accord achieved total operating revenue of approximately RMB 55.066 billion in the first three quarters of 2026, a year-on-year decrease of 0.11%; net profit attributable to shareholders of the listed company was approximately RMB 952 million, a year-on-year decrease of 0.48%; basic earnings per share were RMB 1.56. In the third quarter of 2026, operating revenue was RMB 18.800 billion, a year-on-year increase of 2.57%; net profit attributable to shareholders of the listed company was RMB 346 million, a year-on-year increase of 18.91%.